Spruce Biosciences, Inc. (SPRB)
OTCMKTS
· Delayed Price · Currency is USD
0.0786
-0.0005 (-0.63%)
Apr 28, 2025, 4:00 PM EDT
Spruce Biosciences Revenue
In the year 2024, Spruce Biosciences had annual revenue of $4.91M, down -51.32%. Spruce Biosciences had revenue of $697.00K in the quarter ending December 31, 2024, a decrease of -75.86%.
Revenue
4.91M
Revenue Growth
-51.32%
P/S Ratio
0.64
Revenue / Employee
233.86K
Employees
21
Market Cap
3.12M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Spruce Biosciences News
- 18 days ago - Spruce Biosciences, Inc. (SPRB) Corporate Update Conference Call (Transcript) - Seeking Alpha
- 18 days ago - Spruce Biosciences Announces New Corporate Strategy and Acquisition of Tralesinidase Alfa for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) - Business Wire
- 5 months ago - Penny Stock Spruce Biosciences Winds Down Tildacerfont Studies For Rare Genetic Disorder - Benzinga
- 5 months ago - Spruce Biosciences to wind down investment for genetic disorder drug - Reuters
- 5 months ago - Spruce Biosciences Announces Topline Results from CAHmelia-204 in Adult CAH and CAHptain-205 in Adult and Pediatric CAH - Business Wire
- 6 months ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Business Wire
- 6 months ago - Spruce Biosciences, Inc. Is Being Investigated For Securities Fraud And The Schall Law Firm Urges Affected Shareholders To Reach Out - Accesswire
- 6 months ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Spruce Biosciences Inc For Securities Law Violations - Accesswire